Charlotte R Williams Selected Research

AGN 194204

12/2009	Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.
10/2007	A new rexinoid, NRX194204, prevents carcinogenesis in both the lung and mammary gland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charlotte R Williams Research Topics

Disease

20	Neoplasms (Cancer) 01/2017 - 07/2003
11	Carcinogenesis 01/2016 - 10/2007
11	Breast Neoplasms (Breast Cancer) 01/2015 - 10/2002
8	Lung Neoplasms (Lung Cancer) 01/2016 - 07/2006
6	Inflammation (Inflammations) 01/2017 - 07/2006
3	Leukemia 10/2015 - 07/2003
3	Carcinoma (Carcinomatosis) 10/2015 - 03/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2010
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Adenocarcinoma of Lung 12/2009
1	Hyperplasia 05/2008
1	Adenocarcinoma 03/2007
1	Melanoma (Melanoma, Malignant) 07/2003

Drug/Important Bio-Agent (IBA)

13	TriterpenesIBA 07/2015 - 07/2003
9	bardoxolone methylIBA 07/2015 - 09/2004
8	LG 100268IBA 01/2016 - 10/2002
8	bardoxoloneIBA 10/2015 - 07/2003
7	CarcinogensIBA 01/2016 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2007
6	vinyl carbamateIBA 01/2016 - 03/2007
6	Estrogen ReceptorsIBA 01/2013 - 05/2004
6	AcidsIBA 05/2012 - 09/2004
4	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 10/2015 - 07/2003
4	EstersIBA 05/2012 - 03/2007
3	Pharmaceutical PreparationsIBA 07/2015 - 05/2004
3	oleananeIBA 07/2015 - 12/2009
3	2- cyano- 3,12- dioxooleana- 1,9(11)- dien- 28- oic acid ethyl amideIBA 11/2010 - 03/2007
3	Selective Estrogen Receptor Modulators (SERM)IBA 10/2006 - 10/2002
3	LY 353381 (LY353381)IBA 10/2006 - 10/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2008
2	Histone Deacetylase InhibitorsIBA 01/2016 - 01/2013
2	Vorinostat FDA Link 01/2016 - 01/2013
2	Drug CombinationsIBA 01/2013 - 10/2006
2	ChemokinesIBA 01/2013 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 05/2008
2	Cyclin D1IBA 05/2012 - 01/2012
2	Synthetic DrugsIBA 11/2010 - 12/2009
2	LG 268IBA 11/2010 - 05/2008
2	AGN 194204IBA 12/2009 - 10/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008 - 07/2007
2	EnzymesIBA 08/2008 - 07/2007
2	AmidesIBA 05/2008 - 03/2007
2	Transcription Factors (Transcription Factor)IBA 03/2007 - 07/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	CytokinesIBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	7- (2- (2,2- difluoroethoxy)- 3,5- di- tert- butylbenzene)- 3- methylocta- 2,4,6- trienoic acidIBA 01/2016
1	Dimethyl FumarateIBA 07/2015
1	Lapatinib (GW572016)FDA Link 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	veliparibIBA 07/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014
1	olaparibIBA 07/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013
1	A 7 (A-7)IBA 01/2013
1	Macrophage Colony-Stimulating FactorIBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2012
1	Gemcitabine FDA Link 11/2010
1	NF-E2-Related Factor 2IBA 06/2009
1	AflatoxinsIBA 08/2008
1	TBE 31IBA 08/2008
1	Biological ProductsIBA 05/2008
1	LigandsIBA 05/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2008
1	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2008
1	Betulinic AcidIBA 07/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2007
1	Heme Oxygenase-1IBA 03/2007
1	ritetroniumIBA 10/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2004
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 10/2002

Therapy/Procedure

5	Chemoprevention 07/2014 - 08/2008
2	Therapeutics 01/2017 - 07/2015
1	Oral Administration 01/2013
1	Drug Therapy (Chemotherapy) 08/2008